- Home
- MSGS vs ARWR Comparison
MSGS vs ARWR Comparison
Compare MSGS & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSGS
- ARWR
- Stock Information
- Founded
- MSGS 1879
- ARWR 2003
- Country
- MSGS United States
- ARWR United States
- Employees
- MSGS 1007
- ARWR N/A
- Industry
- MSGS Services-Misc. Amusement & Recreation
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- MSGS Consumer Discretionary
- ARWR Health Care
- Exchange
- MSGS Nasdaq
- ARWR Nasdaq
- Market Cap
- MSGS 5.2B
- ARWR 5.6B
- IPO Year
- MSGS N/A
- ARWR 1993
- Fundamental
- Price
- MSGS $217.12
- ARWR $44.25
- Analyst Decision
- MSGS Buy
- ARWR Buy
- Analyst Count
- MSGS 7
- ARWR 10
- Target Price
- MSGS $260.50
- ARWR $51.40
- AVG Volume (30 Days)
- MSGS 185.8K
- ARWR 2.0M
- Earning Date
- MSGS 10-31-2025
- ARWR 11-25-2025
- Dividend Yield
- MSGS N/A
- ARWR N/A
- EPS Growth
- MSGS N/A
- ARWR N/A
- EPS
- MSGS N/A
- ARWR N/A
- Revenue
- MSGS $1,025,367,000.00
- ARWR $572,976,000.00
- Revenue This Year
- MSGS N/A
- ARWR $21,287.22
- Revenue Next Year
- MSGS $4.61
- ARWR N/A
- P/E Ratio
- MSGS N/A
- ARWR N/A
- Revenue Growth
- MSGS N/A
- ARWR 2816.20
- 52 Week Low
- MSGS $173.26
- ARWR $9.57
- 52 Week High
- MSGS $237.99
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- MSGS 50.77
- ARWR 65.11
- Support Level
- MSGS $213.24
- ARWR $37.06
- Resistance Level
- MSGS $220.15
- ARWR $43.59
- Average True Range (ATR)
- MSGS 4.73
- ARWR 2.59
- MACD
- MSGS -0.27
- ARWR -0.12
- Stochastic Oscillator
- MSGS 55.02
- ARWR 91.68
About MSGS Madison Square Garden Sports Corp. (New)
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.